Key result
ACE inhibitors, angiotensin receptor blockers, and beta-blockers effectively modulate left ventricular remodeling and reduce adverse events after acute myocardial infarction.
This review highlights established therapies (ACEi, ARB, beta-blockers) and emerging experimental targets for preventing left ventricular remodelling after acute myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Supports post-MI ACEi/ARB and beta-blocker use; leaves open novel remodeling targets.
Rossini et al. (2010) conducted a review in Left ventricular remodelling after acute myocardial infarction. ACE inhibitors, Angiotensin Receptor Blockers and Beta-Blockers was evaluated. ACE inhibitors, angiotensin receptor blockers, and beta-blockers effectively modulate left ventricular remodeling and reduce adverse events after acute myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: